Real-world experience with 0.2 μg/day fluocinolone acetonide intravitreal implant (ILUVIEN) in the United Kingdom

AIMS: To compare safety outcomes and visual function data acquired in the real-world setting with FAME study results in eyes treated with 0.2 μg/day fluocinolone acetonide (FAc). METHODS: Fourteen UK clinical sites contributed to pseudoanonymised data collected using the same electronic medical reco...

Descripción completa

Detalles Bibliográficos
Autores principales: Bailey, C, Chakravarthy, U, Lotery, A, Menon, G, Talks, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733285/
https://www.ncbi.nlm.nih.gov/pubmed/28737758
http://dx.doi.org/10.1038/eye.2017.125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733285/
https://www.ncbi.nlm.nih.gov/pubmed/28737758
http://dx.doi.org/10.1038/eye.2017.125

Ejemplares similares